Table 3.
NC | CuSO4, mg/kg |
Cu2O, mg/kg |
SEM |
P-value |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Item | 15 | 75 | 150 | 15 | 75 | 150 | Source | Dose | Source*Dose | |||
BW, g | d 21 | 628.7 | 639.1 | 629.6 | 630.9 | 601.5 | 631.0 | 649.7 | 11.92 | 0.608 | 0.421 | 0.121 |
d 35 | 1684.5ab | 1718.3ab | 1715.4ab | 1710.7ab | 1616.0b | 1718.2ab | 1783.6a | 29.21 | 0.748 | 0.038 | 0.033 | |
d 42 | 2420.8xy | 2505.6xy | 2489.7xy | 2473.8xy | 2404.4y | 2514.9xy | 2585.5x | 37.51 | 0.741 | 0.025 | 0.053 | |
ADG, g/d | d 0-21 | 28.1 | 28.4 | 28.1 | 28.2 | 26.8 | 28.1 | 29.1 | 0.56 | 0.647 | 0.319 | 0.166 |
d 21-35 | 75.0 | 77.0 | 77.6 | 76.7 | 72.5 | 77.7 | 80.6 | 1.70 | 0.912 | 0.060 | 0.113 | |
d 35-42 | 105.2 | 112.5 | 108.5 | 112 | 108.2 | 113.8 | 114.6 | 2.57 | 0.615 | 0.019 | 0.307 | |
d 0-42 | 56.6b | 58.6ab | 58.3ab | 57.9ab | 55.6b | 58.9ab | 60.5a | 0.88 | 0.932 | 0.013 | 0.019 | |
ADFI, g/d | d 0-21 | 43.3AB | 44.0A | 43.0AB | 41.6B | 41.2B | 41.8AB | 43.3AB | 0.53 | 0.127 | 0.371 | 0.001 |
d 21-35 | 133.1ab | 141.3a | 133.2ab | 137.2ab | 131.1b | 131.5b | 136.7ab | 2.03 | 0.032 | 0.062 | 0.043 | |
d 35-42 | 180.6 | 194.2 | 187.4 | 187.6 | 183.3 | 190.8 | 189 | 3.49 | 0.545 | 0.052 | 0.179 | |
d 0-42 | 96.1B | 101.5A | 97.4AB | 97.1AB | 94.8B | 96.5B | 98.7AB | 1.16 | 0.076 | 0.267 | 0.004 | |
FCR, g/g | d 0-21 | 1.54 | 1.55 | 1.53 | 1.48 | 1.54 | 1.49 | 1.49 | 0.02 | 0.425 | 0.035 | 0.612 |
d 21-35 | 1.78 | 1.84 | 1.73 | 1.80 | 1.81 | 1.70 | 1.70 | 0.04 | 0.142 | 0.027 | 0.594 | |
d 35-42 | 1.72 | 1.73 | 1.73 | 1.68 | 1.70 | 1.69 | 1.65 | 0.04 | 0.374 | 0.584 | 0.960 | |
d 0-42 | 1.70 | 1.73 | 1.67 | 1.68 | 1.71 | 1.64 | 1.63 | 0.02 | 0.063 | 0.004 | 0.663 |
Abbreviations: ADG, average daily gain; ADFI, average daily feed intake; BW, body weight; FCR, feed conversion ratio; NC, negative control.
a-bMeans with different superscripts within a row indicate a significant difference of source*dose (P ≤ 0.05).
x-yMeans with different superscripts within a row indicate a tendency toward the significance of source*dose (P ≤ 0.1).
Data are means of 12 replicates per treatment.